Cellular Senescence

Slide 1 · Cellular Senescence

Replication limits, telomeres, tumor suppression, and tissue aging

Telomeres

Cell-cycle checkpoints

Tissue consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain why normal cells eventually cease dividing

Trace telomere shortening to a cell-cycle arrest signal

Describe telomerase and the CDKN2A–RB checkpoint

Relate senescence to aging, cancer, and disease examples

Slide 3 · Senescence within cellular aging

Cellular aging

Progressive decline in function and viability

Accumulation of genetic and molecular injury

Multiple contributing mechanisms

Cellular senescence

A stable nondividing cell state

One contributor to reduced regeneration

Linked to telomere attrition and checkpoints

Slide 4 · Replicative senescence: Definition

A durable arrest of cell division after a finite replicative history.

Applies to normal proliferating somatic cells framework

Different from simple temporary quiescence or repair-associated pause

Slide 5 · Replicative capacity is finite

Repeated cell division

Replicative limit

Stable nondividing state

Slide 6 · Age and replicative potential

Cells from children

Greater remaining capacity for cell divisions

Longer replicative history still lies ahead

Cells from older people

Fewer rounds of replication in culture

Aging is associated with progressive senescence

Slide 7 · Senescence affects replacement capacity

Loss of replicative potential

Reduced generation of new cells

Less replacement after damage

Contribution to tissue aging

Slide 8 · Senescence is only part of aging

Cellular aging

Accumulated DNA damage

Replicative senescence

Defective protein homeostasis

Altered nutrient sensing

Slide 9 · Two mechanisms emphasized

Telomere attrition

Progressive loss of chromosome-end repeats

Short ends signal an apparent DNA break

Tumor suppressor activation

CDKN2A-related suppression of G₁→S

P16 restrains proliferative signaling

Slide 10 · Telomeres protect chromosome ends

Chromosome with protective terminal repeats

Telomere

Telomere

Chromosome arm

Telomere

Telomere

Chromosome arm

Terminal repeated DNA sequences maintain chromosome-end integrity.

Slide 11 · Why chromosome ends need protection

Chromosomes are linear molecules with vulnerable termini

Telomeres protect ends from fusion and degradation

Telomeres assist completion of end replication

Loss of protection can resemble DNA damage

Slide 12 · The end-replication problem

DNA replication

Terminal segment is not copied

Some telomeric DNA is lost

Net shortening across divisions

Slide 13 · Telomere shortening across divisions

Early divisions

More divisions

Near replicative limit

Illustrative progression only — no numerical length scale.

Slide 14 · Telomere loss is cumulative

Each division of most somatic cells leaves a small terminal region unreplicated

Successive divisions progressively shorten telomeres

The process makes proliferative history biologically consequential

Slide 15 · Critically short telomeres signal damage

Short / unprotected telomeres

Chromosome ends perceived as DNA breaks

Damage signaling

Cell-cycle arrest

Slide 16 · Senescence is a protective response

The cell sacrifices further proliferation rather than continue with inadequately protected chromosome ends.

Arrest helps prevent propagation of cells with problematic chromosome termini

The tissue may lose renewal capacity as more cells arrest

Slide 17 · From chromosome to tissue consequence

Telomere attrition

Replicative senescence

Mature-cell division declines

Stem / progenitor pools decline

Impaired cell replacement and tissue function

Slide 18 · Stem and progenitor cell depletion

Replicative senescence can shrink pools that replenish tissues

Reduced progenitor output may limit replacement of damaged cells

Fig. 2.36 links telomere attrition to tissue dysfunction

Slide 19 · Telomerase maintains telomere length

Telomerase adds DNA nucleotides to chromosome ends.

A specialized ribonucleoprotein enzyme complex

Counterbalances telomere loss associated with replication

Slide 20 · Telomerase supplies its own RNA template

Telomerase RNA template

Template-directed nucleotide addition

Telomere extension

Greater maintenance capacity

Slide 21 · Telomerase distribution differs by cell type

Cell population

Textbook description

Consequence

Most somatic tissues

Telomerase absent

Progressive shortening

Stem cells

Low activity

Some maintenance, not complete

Germ cells

Sufficient enzyme activity

Telomere length stabilized

Many cancer cells

Telomerase reactivated

Supports long-term proliferation

Slide 22 · Most somatic cells lack active telomerase

Telomeres generally shorten as ordinary somatic cells replicate

Limited telomere maintenance contributes to finite cell division

This limitation is a basis for replicative senescence

Slide 23 · Stem cells have incomplete maintenance

Stem cells contain telomerase, but typically not enough to stabilize telomere length completely.

Capacity for renewal is greater than in many differentiated somatic cells

Stem-cell exhaustion remains a possible downstream consequence

Slide 24 · Germ cells maintain telomeres

Telomerase activity in germ cells is sufficient to stabilize telomere length.

Contrasts with progressive attrition in most somatic cells

Illustrates how replicative limits depend on telomere maintenance

Slide 25 · Cancer cells frequently reactivate telomerase

Telomerase reactivation

Telomere stabilization

Sustained replicative capacity

Contribution to cellular immortality

Slide 26 · Telomerase alters a critical trade-off

Limited telomerase

Replicative arrest can protect genomic integrity

Cell renewal becomes constrained with time

Reactivated telomerase

Replicative barrier is bypassed

Indefinite proliferation becomes possible in cancers

Slide 27 · What the telomere diagram establishes

Repeated divisions shorten telomeres in most somatic cells

Germ and stem cells differ in telomerase activity

Cancer cells can stabilize telomeres by telomerase reactivation

The relationship is mechanistic, not a diagnostic cutoff

Slide 28 · Short-telomere mouse models

Genetically shortened telomeres

Reduced lifespan in mice

Telomerase activation

Lifespan restored toward normal

Slide 29 · Interpret animal experiments carefully

What Robbins supports

Causal role for telomere length in mouse models

Telomerase activation reversed a lifespan deficit in that setting

What cannot be inferred

A general human anti-aging prescription

Known long-term safety of activating telomerase in humans

Slide 30 · Short telomeres and pulmonary fibrosis

The textbook links telomere shortening with premature development of pulmonary fibrosis.

Provides a disease-oriented example of tissue consequences

The section does not supply a clinical diagnostic algorithm or penetrance estimate

Slide 31 · Short telomeres and aplastic anemia

Telomere shortening is also associated with premature development of aplastic anemia.

Emphasizes the importance of replenishing hematopoietic cells

This is an association in the cited section; Avoid assuming a single etiology

Slide 32 · Why regenerative tissues are vulnerable

Ongoing cellular turnover

Repeated progenitor division

Telomere-dependent proliferative limits

Diminished cell replacement

Slide 33 · Tumor suppressors also induce arrest

Replicative senescence can be reinforced by activation of cell-cycle inhibitory genes.

Robbins singles out proteins encoded by CDKN2A

The relevant checkpoint lies at entry into S phase

Slide 34 · CDKN2A produces two tumor suppressors

P16 / INK4a

Inhibits cyclin D–CDK4 signaling

Reinforces the active RB brake

P14 / ARF

Inhibits MDM2-mediated p53 restraint

Raises p53 under oncogenic stress

Slide 35 · P16 expression increases with age

P16/INK4a expression correlates with chronological age

This correlation in many human and mouse tissues

Correlation does not establish a universal single-cell age clock

Slide 36 · P16 inhibits G₁-to-S progression

P16 / INK4a

Cyclin D–CDK4 inhibition

RB remains active

E2F remains inhibited

G₁/S progression is blocked

Slide 37 · RB is the G₁/S gatekeeper

Active RB: Hypophosphorylated

Binds E2F transcription factors

Restrains S-phase gene transcription

Inactive RB: Hyperphosphorylated

Releases its antiproliferative restraint

Allows G₁→S progression

Slide 38 · P16 shields against excessive mitogenic drive

Persistent mitogenic signals

P16-related checkpoint restraint

Suppressed inappropriate G₁/S entry

Senescence pathway

Slide 39 · Two pathways converge on one outcome

Replicative / oncogenic stress

Anti-proliferative signaling

Short telomere damage response

CDKN2A–p16–RB checkpoint

Durable block in cell division

Slide 40 · Oncogenic stress can raise p53

Excess RAS-like growth signaling

P14 / ARF increases

MDM2 inhibition

P53 accumulation

Slide 41 · MDM2 restrains unstressed p53

In healthy unstressed cells, MDM2 targets p53 for degradation.

This keeps p53 protein levels low

Stress interrupts this inhibitory relationship

Slide 42 · DNA damage stabilizes p53

DNA damage or hypoxia

ATM / ATR kinases activated

P53 protected from MDM2

P53 increases

Slide 43 · P53 induces the CDK inhibitor p21

Activated p53

CDKN1A transcription

P21 protein

CDK inhibition

G₁ arrest

Slide 44 · P21 and p16 intersect at RB

P16 route

CDKN2A → p16

Restrains cyclin D–CDK4

Maintains active RB

P53–p21 route

TP53 → CDKN1A → p21

Inhibits cyclin–CDK complexes

Maintains active RB

Slide 45 · A temporary pause permits repair

DNA damage

Transient p53–p21 arrest

DNA repair succeeds

P53 levels fall

Cell cycle may resume

Slide 46 · Persistent damage can end in senescence

Persistent damage signaling

Sustained checkpoint response

Stable cell-cycle arrest

Senescence

Slide 47 · Irreparable damage can lead to apoptosis

Persistent severe damage

P53 pro-apoptotic transcription

Intrinsic apoptotic pathway

Cell eliminated

Slide 48 · P53 has multiple cell-fate outputs

P53 activation by stress

Cell-fate regulation

Transient arrest and repair

Senescence or apoptosis

Prevention of propagation of damaged genomes

Slide 49 · Reversible arrest versus senescence

Transient cell-cycle arrest

Temporary pause in cell-cycle progression

Damage repair may restore cycling

Cellular senescence

Durable, essentially permanent arrest

Associated changes in gene expression and morphology

Slide 50 · Senescence versus apoptosis

Senescence

Cell persists in a nonproliferative state

Prevents division of stressed cells

Apoptosis

The damaged cell is eliminated

A distinct p53-associated protective fate

Slide 51 · Morphology is not a stand-alone definition

Morphology and gene-expression changes in p53-induced senescence

The supplied section does not define a universal H&E appearance

Demonstrating senescence is not equivalent to naming a specific diagnostic stain

Slide 52 · Aging and tumor suppression pull in tension

Protective consequence

Restricts growth of genomically stressed cells

Provides a barrier to neoplastic transformation

Cost of persistent arrest

Reduced proliferative reserve

Potentially diminished renewal of damaged tissue

Slide 53 · Loss of a senescence checkpoint favors cancer

Impaired RB or p53 restraint

Genetically altered cells keep dividing

Further mutations may accumulate

Risk of neoplastic progression

Slide 54 · Senescence cannot be reduced to telomeres

Multiple stress inputs

Short telomeres

DNA damage

Oncogenic signaling

Hypoxic stress

Slide 55 · Clinical application: Tissue failure

Teaching case — hypothetical

A patient has a condition involving premature shortening of telomeres and impaired renewal of a normally proliferating tissue.

1. Which cell population is especially important for maintaining replacement?

2. How could a telomere-associated arrest contribute to dysfunction?

Slide 56 · Application answer: Tissue failure

Stem and progenitor populations support continual replacement

Telomere attrition may restrict their ability to proliferate

A reduced pool of replacements can contribute to functional decline

The scenario does not identify a specific disorder on its own

Slide 57 · Clinical application: Unchecked proliferation

Teaching case — hypothetical

A stressed cell contains substantial DNA damage but fails to activate a functional p53 checkpoint.

1. What normal arrest or repair responses are lost?

2. Why might continued division create a neoplastic risk?

Slide 58 · Application answer: Checkpoint failure

The DNA damage response may fail to initiate adequate arrest

Mutated cells can continue to cycle rather than repair or exit

Expansion creates opportunities for additional oncogenic changes

This is a mechanism, not a guarantee of cancer in any one cell

Slide 59 · Mechanism integration

Replicative history and stress

Telomeres, p16–RB, p53–p21

Stable arrest: Senescence

Failed arrest: Proliferation

Trade-off: Tumor restraint versus renewal capacity

Slide 60 · Cellular senescence: Essential distinctions

Concept

Mechanism

Consequence

Replicative senescence

Telomere shortening with divisions

Stable arrest

CDKN2A–p16

Inhibits cyclin D–CDK4 / supports RB

Blocks G₁/S

p53–p21

Checkpoint response to stress

Pause; possible senescence

Telomerase reactivation

Maintains telomere ends

Sustained replication in cancers

Slide 61 · Source references

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026).

Chapter 2: Cell Injury, Cell Death, and Adaptations — Cellular Aging; Cellular Senescence (pp. 60–61).

Chapter 2, Fig. 2.36: telomeres, telomerase, and replicative senescence.

Chapter 7: Neoplasia — cell-cycle control, RB, CDKN2A, TP53 (pp. 260–264).

Chapter 7, Table 7.6 and Fig. 7.27: cyclin–CDK inhibitors and p53 responses.